Rossari Biotech Ltd Stock Price Today (NSE: ROSSARI)

Rossari Biotech Ltd

512.451.05 (0.20%)
Market Closed

Fundamental Score

...

Rossari Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Rossari Biotech Ltd share price today is 512.45, down 0.20% on NSE/BSE as of 17 June 2026. Rossari Biotech Ltd (ROSSARI) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 3.32K (Cr). The 52-week high for ROSSARI share price is 766.00 and the 52-week low is 375.00. At a P/E ratio of 24.31x, ROSSARI is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 12.22% and a debt-to-equity ratio of 0.28.

Rossari Biotech Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
560.00
Low
458.15
Volume
3.8L
Change
+6.55%

Rossari Biotech Ltd share price chart: 6.55% return over the past month. 52-week high ₹766.00, 52-week low ₹375.00.

Rossari Biotech Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
518.05549.45515.70543.651.90L (Cr)
528.90528.90515.00522.1587.24K (Cr)
537.10537.20513.45518.8560.42K (Cr)
543.70548.60533.30537.201.09L (Cr)
539.90552.55531.35543.751.24L (Cr)
525.10547.00520.60538.452.26L (Cr)
520.00533.75515.50524.0095.22K (Cr)
517.25539.00506.05518.153.03L (Cr)
500.00514.80492.90507.401.16L (Cr)
505.00509.50500.50504.9552.73K (Cr)

Rossari Biotech Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
528.90549.45515.00543.65+2.79%
478.95560.00469.00518.85+8.33%
398.60525.00386.50478.95+20.16%
491.00496.25375.00378.60-22.89%
535.00559.00490.00496.25-7.24%
584.00604.80501.90564.40-3.36%
608.00616.10562.35582.15-4.25%
644.00654.00592.00600.15-6.81%
623.00690.30615.15640.95+2.88%
625.30685.50614.00618.35-1.11%
708.95713.10611.40618.15-12.81%
696.00766.00666.00705.10+1.31%

AI Research Briefing

Powered by Gemini · 2026-04-10

Rossari's Saudi gamble could unlock value, but execution risk is high in this small-cap name.

Research Confidence
6.0/10Moderate
OPERATOR-DRIVENBreakdown - 1M: -6.3%, 3M: -4.19%, 6M: -12.32%.Fair - P/E of 24.31x vs Industry P/E of 29.2x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Rossari Biotech is gearing up to announce its Q4 FY26 results in May 2026. Analyst estimates project revenue between -690 Cr and PAT between -54 Cr. The board is also expected to consider a final dividend of -5 per share.

CORE STORY (THE REAL GAME)

Rossari is a specialty chemicals player undergoing a transition, shifting capital from underperforming assets to more ambitious ventures in the Middle East. The market is watching to see if they can maintain growth while optimizing their portfolio.

Why Now
  • Upcoming Q4 FY26 results in May 2026
  • Saudi Arabia expansion plans
  • Q3 FY26 revenue growth of 13% YoY
Potential Catalysts
  • Positive Q4 FY26 results exceeding analyst estimates
  • Successful commissioning of Saudi Arabian manufacturing facilities
  • New order wins or contract announcements
Key Risks
  • Small-cap liquidity risk
  • Soft domestic demand
  • Geopolitical risks impacting global trade
Institutional Activity

FII decreased holdings by 0.78%, while DII increased holdings by 0.34%.

Macro Context

Indian chemical production is projected to increase by 10.9% in 2026, driven by robust domestic demand and government support.

Order Book / Expansion

Board has granted in-principle approval to set up greenfield specialty chemicals manufacturing facilities in the Kingdom of Saudi Arabia (KSA).

Cash Flow Quality

No - Free Cash Flow 5Y: ₹1.71 Cr.

3–6 Month Outlook

Rossari's 3-6 month outlook hinges on Q4 results and progress on the Saudi expansion. Success depends on navigating near-term volatility and delivering consistent, profitable growth.

Primary Thesis Risk

Failure to execute Saudi expansion will crush the narrative.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

12.22%

Profit generated per ₹1 of shareholder equity

Average

Return on Capital (ROCE)

15.80%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

13.47%

Average operating profit margin over 5 years

Dividend Yield

0.08%

Annual dividend as % of current share price

Rossari Biotech Ltd Valuation Check

Good

Price to Earnings (P/E)

24.31x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

29.20x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

68.17%

% shares held by company founders/management

Poor

FII Holding

2.70%

% shares held by foreign institutional investors

Good

DII Holding

18.18%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

4.39%

Net profit growth vs same quarter last year

Good

Revenue Growth (Quarterly YoY)

17.61%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

28.23%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

13.88%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

15.88%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.28x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

9.35x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

1.71 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Rossari Biotech Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ROSSARI across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Excellent ROCE Performance (15.80%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Revenue Growth (17.61%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (28.23% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (15.88% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.28)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (9.35x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (68.17%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

0 factors identified

No significant concerns identified in current analysis.

Rossari Biotech Ltd vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Rossari Biotech Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
53.6/100
512
₹3321.22
24.3
Average
12.22%
Average
15.80%
Good
0.3
Excellent
15.88%
Excellent
28.23%
Excellent
0.08%
60.4/100
1481
₹149466.57
66.6
Average
23.05%
Excellent
29.84%
Excellent
0.1
Excellent
12.63%
Good
12.49%
Good
0.68%
51.5/100
3682
₹37241.99
54.8
Average
8.29%
Poor
9.89%
Poor
0.2
Excellent
21.05%
Excellent
12.69%
Good
0.09%
40.6/100
7245
₹29462.02
66.3
Average
11.52%
Average
11.68%
Average
0.3
Excellent
-6.59%
Poor
17.22%
Excellent
0.21%
40.2/100
1715
₹21083.64
39.7
Average
13.36%
Average
16.28%
Good
0.2
Excellent
2.02%
Average
14.38%
Good
0.49%
52/100
3430
₹17807.40
46.3
Average
13.73%
Average
18.02%
Good
0.0
Excellent
57.98%
Excellent
14.83%
Good
0.49%
Atul Ltd...
ATUL500027
50.5/100
7003
₹17066.13
31.5
Average
9.10%
Poor
12.81%
Average
0.0
Excellent
-5.82%
Poor
6.41%
Good
0.43%
57.2/100
1325
₹16256.72
35.0
Average
15.75%
Good
20.61%
Excellent
0.0
Excellent
4.46%
Average
16.92%
Excellent
0.48%
37.5/100
1368
₹14036.52
92.8
Average
3.32%
Poor
7.33%
Poor
0.4
Excellent
11.97%
Good
22.13%
Excellent
0.06%
41.9/100
501
₹13796.68
51.3
Average
6.03%
Poor
6.32%
Poor
0.7
Good
-9.09%
Poor
11.68%
Good
0.26%
60.5/100
4677
₹13359.76
33.4
Average
19.47%
Good
26.39%
Excellent
0.0
Excellent
20.04%
Excellent
16.93%
Excellent
0.25%

Rossari Biotech Ltd PE Ratio History

Historical price-to-earnings ratio for ROSSARI — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202524.63₹582.1523.6x
FY 202423.62₹777.2032.9x
FY 202319.38₹799.1541.2x
FY 202217.70₹727.1541.1x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Rossari Biotech Ltd Dividend History

Annual cash dividends paid by ROSSARI — dividend yield 0.08%

Financial YearDividends Paid (₹ Cr)
FY 20252.77 Cr
FY 20242.76 Cr
FY 20232.75 Cr
FY 20222.75 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Rossari Biotech Ltd Quarterly Performance

Latest quarterly metrics for ROSSARI — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

17.61%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

4.39%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

28.23%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

15.88%

Compounded annual net profit growth over 5 years

Rossari Biotech Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ROSSARI — calculated from daily price history

49RSI 14
Neutral — RSI 49

Momentum is balanced — neither overbought nor oversold.

SMA 50
475
▲ Price above SMA 50 — Short-term bullish
SMA 200
563
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
364K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Rossari Biotech Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Rossari Biotech Ltd (ROSSARI) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Rossari Biotech Ltd

About ROSSARI (Rossari Biotech Ltd)

Rossari Biotech Ltd is a dynamic player in the specialty chemicals sector, focusing on innovative solutions that cater to a wide range of industrial applications. Their expertise l...ies in formulating and manufacturing specialized chemical products designed to enhance performance and sustainability across various sectors. Rossari Biotech Ltd's commitment to research and development allows them to create tailored solutions that meet the evolving needs of their clients, ensuring superior quality and efficiency. Their dedication to environmental responsibility drives their development of eco-friendly products, contributing to a more sustainable future for the industry. Rossari Biotech Ltd offers a diverse portfolio of specialty chemicals, catering to multiple industries, from textiles to home and personal care. Their product range includes performance-enhancing additives for soaps and detergents, specialized chemicals for paints and coatings, and solutions for the ceramics, pulp and paper, and cement industries. They also provide a comprehensive suite of water treatment solutions designed to optimize water usage and reduce environmental impact. Rossari Biotech Ltd's commitment to innovation ensures that their products meet the highest standards of quality and performance, enabling their customers to achieve their goals efficiently and effectively. Rossari Biotech Ltd distinguishes itself through its unwavering commitment to sustainability and customer-centric approach. Their textile specialty chemicals provide innovative solutions for cotton, polyester, and other fabrics, while their pet grooming products offer natural and safe options for pet owners. By prioritizing research and development, Rossari Biotech Ltd continues to develop cutting-edge solutions that address emerging challenges and opportunities in the specialty chemicals market. Their focus on environmental responsibility and customer satisfaction positions them as a trusted partner for industries seeking sustainable and high-performing chemical solutions.

Company Details

Symbol:ROSSARI
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Edward Walter Menezes
Co-Founder & Executive Chairman
Mr. Sunil Srinivasan Chari
Co-Founder, MD & Director
Mr. Ketan Sablok
Group Chief Financial Officer

ROSSARI Share Price: Frequently Asked Questions

What is the current share price of Rossari Biotech Ltd?

Rossari Biotech Ltd (ROSSARI) trades at ₹512.45 on NSE and BSE. Market cap ₹3.32K (Cr). Educational data only.

What is the P/E ratio of Rossari Biotech Ltd?

Rossari Biotech Ltd has a P/E of 24.31x vs industry average 29.20x.

What is the Bull Run score for Rossari Biotech Ltd?

Rossari Biotech Ltd has a Bull Run score of 53.6/100 based on 25+ financial parameters.

Does Rossari Biotech Ltd pay dividends?

Rossari Biotech Ltd has a dividend yield of 0.08%. Past dividends don't guarantee future payments.

What is the ROE of Rossari Biotech Ltd?

Rossari Biotech Ltd has ROE of 12.22%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Rossari Biotech Ltd?

Rossari Biotech Ltd has debt-to-equity of 0.28.

Is Rossari Biotech Ltd a good investment?

Bull Run gives Rossari Biotech Ltd a score of 53.6/100. This is not investment advice — consult a SEBI-registered advisor.